1. MAPK/ERK Pathway
  2. MAP3K

MAP3K

 

MAP3K Related Products (5):

Cat. No. Product Name Effect Purity
  • HY-15434
    NG25 Inhibitor 98.05%
    NG25 is a potent dual TAK1 and MAP4K2 inhibitor, with IC50s of 149 nM and 21.7 nM, respectively.
  • HY-18938
    Selonsertib Inhibitor 98.04%
    GS-4997 is a highly selective and potent once-daily oral ASK1 inhibitor that competes with ATP in the ASK1 catalytic kinase domain.
  • HY-103490
    Takinib Inhibitor 98.00%
    Takinib is a potent and selective TAK1 inhibitor with an IC50 of 9.5 nM.
  • HY-19566
    NQDI-1 Inhibitor 98.04%
    NQDI-1 inhibits apoptosis signal-regulating kinase 1 (ASK1) with a Ki of 500 nM.
  • HY-100844
    ASK1-IN-1 Inhibitor 99.33%
    ASK1-IN-1 is an apoptosis signal regulating kinase 1 (ASK1) inhibitor extracted from patent WO2016025474A1, Compound 4.